Showing 121-130 of 3024 results for "".
Radiologic Biomarkers in Multiple Sclerosis: Improving Detection and Diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-biomarkers-in-multiple-sclerosis-improving-detection-and-diagnosis/54604/Imaging biomarkers, including cortical lesions, the central vein sign, and paramagnetic rim lesions, allow for more timely and accurate diagnosis of multiple sclerosis.Young-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroRadiologic Differential Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-differential-diagnosis-of-multiple-sclerosis/54601/This article provides an overview of the radiographic features that are shared and those that are distinct among multiple sclerosis, aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte protein antibody–associated disease.Adult-Onset Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/adult-onset-cerebellar-ataxias/31221/Pravin Khemani, MD, Medical Director, Movement Disorders Program, Swedish Neuroscience Institute, provides a framework for evaluation of adult-onset cerebellar ataxias.ELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.A Mark of Success?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-mark-of-success/31075/Achim Schneeberger, MD, talks about the Phase II study that demonstrated clinical and biomarker effects consistent with disease modification in Alzheimer's. (headphones recommended)Advances in the Evaluation of TBI
https://practicalneurology.com/diseases-diagnoses/tbi/advances-in-the-evaluation-of-tbi/30093/Welcome to Neurology: Disease Deep Dive. In this episode, Dr. Beth McQuiston, MD, RD, Medical Director at Abbott Laboratories, and Dr. David Okonkwo, MD, PhD, Professor of Neurological Surgery, Clinical Director of the Brain Trauma Research Center, and Director of the Neurotrauma Program at UniversiA Coming of Age for Neuroimmunology
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-coming-of-age-for-neuroimmunology/30122/Increasingly complex diagnostics and highly effective disease-modifying therapy come with challenges in clinical decision making.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.In-Focus: Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/in-focus-multiple-sclerosis/30371/Retooling Multiple Sclerosis Care